In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

PregLem SA closes its CHF32mm Series A venture round

Executive Summary

Concurrent with the signing of an alliance with Ipsen, PregLem SA (gynecology therapeutics) has closed its CHF32mm ($26mm) Series A venture round. Lead investor Sofinnova Partners was joined by fellow backers NeoMed Management and MVM Life Science Partners.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies